Pat
J-GLOBAL ID:202303001058122906

新規フザラミン物質を有効成分とする白血病細胞増殖抑制剤

Inventor:
Applicant, Patent owner:
Agent (1): 名古屋国際弁理士法人
Gazette classification:特許公報
Application number (International application number):2019110891
Publication number (International publication number):2020164502
Patent number:7389448
Application date: Jun. 14, 2019
Publication date: Oct. 08, 2020
Claim (excerpt):
【請求項1】 下記式で表されるフザラミン物質若しくはその塩、又はその水和物若しくは溶媒和物。
IPC (7):
C07D 207/448 ( 200 6.01) ,  A61K 31/4015 ( 200 6.01) ,  A61K 36/06 ( 200 6.01) ,  A61P 35/02 ( 200 6.01) ,  A61P 31/04 ( 200 6.01) ,  C12P 1/02 ( 200 6.01) ,  C12N 1/14 ( 200 6.01)
FI (7):
C07D 207/448 CSP ,  A61K 31/401 ,  A61K 36/06 Z ,  A61P 35/02 ,  A61P 31/04 ,  C12P 1/02 Z ,  C12N 1/14 A
Article cited by the Patent:
Cited by examiner (3)
  • Fungal Genetics and Biology, 2016, Vol. 89, p.37-51
  • Chemistry & Biodiversity, 2010, Vol. 7, No. 12, p.2830-2845
  • Organic & Biomolecular Chemistry, 2007, Vol. 5, No. 11, p.1702

Return to Previous Page